Practice
The resurgence of pertussis
J. Brad Wiggers, Jerome A. Leis and Wayne L. Gold
CMAJ July 14, 2015 187 (10) 755; DOI: https://doi.org/10.1503/cmaj.140896
J. Brad Wiggers
Department of Medicine (Wiggers), University of Toronto; Division of Infectious Diseases (Leis, Gold), Department of Medicine, University of Toronto; Centre for Quality Improvement and Patient Safety (Leis), University of Toronto, Toronto, Ont.
MDJerome A. Leis
Department of Medicine (Wiggers), University of Toronto; Division of Infectious Diseases (Leis, Gold), Department of Medicine, University of Toronto; Centre for Quality Improvement and Patient Safety (Leis), University of Toronto, Toronto, Ont.
MD MScWayne L. Gold
Department of Medicine (Wiggers), University of Toronto; Division of Infectious Diseases (Leis, Gold), Department of Medicine, University of Toronto; Centre for Quality Improvement and Patient Safety (Leis), University of Toronto, Toronto, Ont.
MDData supplements
Related Articles
- (2015). Highlights. CMAJ, 187(10), 711. Accessed April 17, 2024. Retrieved from http://www.cmaj.ca/content/187/10/711.
In this issue
Article tools
Respond to this article
The resurgence of pertussis
J. Brad Wiggers, Jerome A. Leis, Wayne L. Gold
CMAJ Jul 2015, 187 (10) 755; DOI: 10.1503/cmaj.140896
Jump to section
- Article
- Pertussis is a highly communicable respiratory tract infection
- The resurgence of pertussis has been linked to waning immunity
- The diagnostic test of choice is polymerase chain reaction testing of a nasopharyngeal aspirate
- Macrolides are the mainstay of therapy and prophylaxis
- Pertussis vaccines are indicated for children, adolescents and adults
- Footnotes
- References
- Figures & Tables
- Related Content
- Responses
- Metrics
Related Articles
Cited By...
- No citing articles found.